InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,363.32
(
0.18%
)
Post# of 42458
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: SwingKing post# 18657

Tuesday, 01/14/2014 10:09:35 AM

Tuesday, January 14, 2014 10:09:35 AM

Post# of 42458
RNA: From J.P. Morgan Healthcare Confab News Dump: RNA is rated HOLD, based on 5 Wall Street analysts' reports. Analysts have an average $6.68 Target Price on RNA, implying 34.9% Upside to its current price of $4.95.

There's also a fair amount of buyout talk. Yesterday's situation with GSK and disapersen (RNA's lead drug) doesn't help, but they've got a full pipeline.


All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up